-
Hardcover: US: A fervent plea to renew an old idea
(20 Mar 2010 16:41)
... The British historian Tony Judt is dying, slowly and painfully, from a variant of amyotrophic lateral sclerosis (ALS), better known as Lou Gehrigs disease. He has written matter-of-factly about his condition ...
-
It's hard to vanquish evil, selfish thoughts
(20 Mar 2010 02:59)
... Is Precious is written by Rob Payne, whose wife, Marcy, was diagnosed with ALS (Lou Gehrig's disease) in August of 2000. ...
-
Local Woman Battling ALS Has 2 Wishes Granted
(20 Mar 2010 05:17)
... can only communicate with her eyes. She had ALS, which is better known as Lou Gehrig's disease. She's been in a Pensacola hospital on a ventilator for two weeks. She was ...
-
Trophos Completes Patient Enrolment In Pivotal Phase 3 Efficacy Study Of Olesoxime In Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
(19 Mar 2010 09:00)
... the clinical trial, MitoTarget aims to enlarge the understanding of mitochondrial dysfunction in neurodegenerative diseases and assess the therapeutic potential of Trophos' novel proprietary class of mitochondrial pore modulator ...
-
Cytokinetics Announces Opening of a Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 for Patients With Amyotrophic Lateral Sclerosis (MRW)
(19 Mar 2010 12:04)
... applications that this novel drug candidate may have in diseases of impaired muscle function." Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that afflicts 20,000 to 30,000 people in the ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
-
www.StockMarketingInc.com: Welcome To Stock Marketing Inc!! Sign Up Today!! CYTK,CVGI,CRTP,HSGI,AMCC,OXGN
(19 Mar 2010 17:02)
... of a Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 for Patients With Amyotrophic Lateral Sclerosis SOUTH SAN FRANCISCO, CA, Mar 19, 2010 -- Cytokinetics, Incorporated (NASDAQ: CYTK) announced today ...
-
Botox Applications: A Review of Risks and Benefits
(19 Mar 2010 13:28)
... U is injected into the medial and lateral pretarsal orbicularis oculi of the upper lid ... as myasthenia gravis or neuropathic disorders (e.g., amyotrophic lateral sclerosis). Reduced blinking from injection of the orbicularis ...
-
Student wins prize for 'designer wheat'
(19 Mar 2010 17:59)
... in green tea to promote growth of nerve cells in a study related to amyotrophic lateral sclerosis, also known as Lou Gehrigs disease. He is hoping to attend Dalhousie University in ...
-
Woman Battling ALS Making Special Trip Home
(19 Mar 2010 05:02)
... with her family and children by her side. Lavanna Ray was recently diagnosed with Lou Gehrig's disease. Her family is shocked by how fast the disease progressed. "She was always the ...
-
Biography: The fierce, fervent and festive world of Joe Kelly, 1966-2010
(19 Mar 2010 05:14)
... of his 44th birthday, in Provincetown, Mass., of complications from ALS, also known as Lou Gehrig's disease. His friends and family are gathering Saturday night to celebrate his life and art. ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
-
College Killer Had Long History of Mental Illness
(19 Mar 2010 01:57)
... professor is quoted as saying in the report. The death of Kazmierczak's mother from Lou Gehrig's disease in September 2006 marked the start of series of events that reinflamed his mental ...
-
Trophos Completes Patient Enrolment in Phase 3 Olesoxime Study in ALS (Lou Gehrig's Disease)
(18 Mar 2010 15:53)
... over 500 patients recruited into the pivotal phase 3 efficacy study of olesoxime in Amyotrophic Lateral Sclerosis (ALS). The study is supported by the EU FP7 MitoTarget project (see below). The ...
-
Reportlinker Adds Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market F
(16 Mar 2010 18:11)
... Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016 "Amyotrophic lateral sclerosis ...
-
Research and Markets: Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016
(15 Mar 2010 15:31)
... the future market associated with ALS. Key Topics Covered: 1 Table of contents 2 Amyotrophic Lateral Sclerosis Therapeutics Market: Market Characterization 3 Amyotrophic Lateral Sclerosis Therapeutics Market: Competitive Assessment 4 Amyotrophic ...
-
Reportlinker Adds Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016
(16 Mar 2010 17:50)
... pipeline. - Develop business strategies by understanding the trends shaping and driving the global amyotrophic lateral sclerosis market. - Drive revenues by understanding key trends, innovative products and technologies, market segments ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.